{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:39:07Z","timestamp":1778218747635,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research, Fujian Medical University","award":["2020QH1115"],"award-info":[{"award-number":["2020QH1115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The TOR1B gene is known to play a pivotal role in maintaining cellular homeostasis and responding to endoplasmic reticulum stress. However, its involvement in cancer remains relatively understudied. This study seeks to explore the prognostic implications of TOR1B across various cancers, with a specific focus on Basal-like Breast Cancer (BLBC) and its underlying cellular mechanisms. Through comprehensive analysis of data from TCGA, TARGET, GEO, and GTEx, we investigated TOR1B expression and its correlation with patient outcomes. Furthermore, in vitro experiments conducted on BLBC cell lines examined the impact of TOR1B modulation on cell viability, apoptosis, and metabolic activity under varying oxygen levels. Our statistical analysis encompassed differential expression analysis, survival analysis, and multivariate Cox regression. Our findings indicate that TOR1B is overexpressed in BLBC and other cancers, consistently correlating with poorer prognosis. Elevated TOR1B levels were significantly associated with reduced overall and disease-free survival in BLBC patients. In vitro experiments further revealed that TOR1B knockdown augmented apoptosis and influenced metabolic activity, particularly under hypoxic conditions, highlighting its potential role in cancer cell adaptation to stress. Overall, our study underscores the importance of TOR1B in cancer progression, particularly in BLBC, where it serves as a notable prognostic indicator. The interaction between TOR1B and metabolic pathways, as well as its regulation by HIF-1\u03b1, suggests its significance in adapting to hypoxia, thereby positioning TOR1B as a promising therapeutic target for aggressive breast cancer subtypes.<\/jats:p>","DOI":"10.1007\/s00432-024-05794-3","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:02:24Z","timestamp":1717675344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic implications of TOR1B expression across cancer types: a focus on basal-like breast cancer and cellular adaptations to hypoxia"],"prefix":"10.1007","volume":"150","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-8708","authenticated-orcid":false,"given":"Xinquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"5794_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/ijms20030667","volume":"20","author":"S Alexandrou","year":"2019","unstructured":"Alexandrou S, George SM, Ormandy CJ, Lim E, Oakes SR, Caldon CE (2019) The proliferative and apoptotic landscape of basal-like breast cancer. Int J Mol Sci 20:667. https:\/\/doi.org\/10.3390\/ijms20030667","journal-title":"Int J Mol Sci"},{"key":"5794_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5114\/wo.2016.56938","volume":"20","author":"AM Badowska-Kozakiewicz","year":"2016","unstructured":"Badowska-Kozakiewicz AM, Budzik MP (2016) Immunohistochemical characteristics of basal-like breast cancer. Contemp Oncol (pozn) 20:436\u2013443. https:\/\/doi.org\/10.5114\/wo.2016.56938","journal-title":"Contemp Oncol (pozn)"},{"key":"5794_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","volume":"74","author":"IB Barsoum","year":"2014","unstructured":"Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74:665\u2013674. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0992","journal-title":"Cancer Res"},{"key":"5794_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13048-020-00646-3","volume":"13","author":"L Duan","year":"2020","unstructured":"Duan L et al (2020) HVEM\/HIF-1\u03b1 promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions. J Ovarian Res 13:40. https:\/\/doi.org\/10.1186\/s13048-020-00646-3","journal-title":"J Ovarian Res"},{"key":"5794_CR5","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/1078-0432.CCR-05-2690","volume":"12","author":"D Generali","year":"2006","unstructured":"Generali D et al (2006) Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12:4562\u20134568. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2690","journal-title":"Clin Cancer Res"},{"key":"5794_CR6","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.18632\/oncotarget.3257","volume":"6","author":"X Jia","year":"2015","unstructured":"Jia X et al (2015) Basal and therapy-driven hypoxia-inducible factor-1alpha confers resistance to endocrine therapy in estrogen receptor-positive breast cancer. Oncotarget 6:8648\u20138662. https:\/\/doi.org\/10.18632\/oncotarget.3257","journal-title":"Oncotarget"},{"key":"5794_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12935-020-01370-0","volume":"20","author":"X Jin","year":"2020","unstructured":"Jin X, Dai L, Ma Y, Wang J, Liu Z (2020) Implications of HIF-1\u03b1 in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int 20:273. https:\/\/doi.org\/10.1186\/s12935-020-01370-0","journal-title":"Cancer Cell Int"},{"key":"5794_CR8","doi-asserted-by":"publisher","first-page":"e0226150","DOI":"10.1371\/journal.pone.0226150","volume":"14","author":"A J\u00f6gi","year":"2019","unstructured":"J\u00f6gi A, Ehinger A, Hartman L, Alkner S (2019) Expression of HIF-1\u03b1 is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer. PLoS ONE 14:e0226150. https:\/\/doi.org\/10.1371\/journal.pone.0226150","journal-title":"PLoS ONE"},{"key":"5794_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1078-0432.CCR-14-2011","volume":"21","author":"K Kleivi Sahlberg","year":"2015","unstructured":"Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Borresen-Dale AL, Santarpia L (2015) A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res 21:1207\u20131214. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2011","journal-title":"Clin Cancer Res"},{"key":"5794_CR10","doi-asserted-by":"publisher","first-page":"63614","DOI":"10.7554\/eLife.63614","volume":"9","author":"N Luithle","year":"2020","unstructured":"Luithle N et al (2020) Torsin ATPases influence chromatin interaction of the Torsin regulator LAP1. Elife 9:63614. https:\/\/doi.org\/10.7554\/eLife.63614","journal-title":"Elife"},{"key":"5794_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41598-023-28140-y","volume":"13","author":"MN Nguyen","year":"2023","unstructured":"Nguyen MN et al (2023) TOR1B: a predictor of bone metastasis in breast cancer patients. Sci Rep 13:1495. https:\/\/doi.org\/10.1038\/s41598-023-28140-y","journal-title":"Sci Rep"},{"key":"5794_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3109\/10409238.2015.1091804","volume":"50","author":"AE Rose","year":"2015","unstructured":"Rose AE, Brown RS, Schlieker C (2015) Torsins: not your typical AAA+ ATPases. Crit Rev Biochem Mol Biol 50:532\u2013549. https:\/\/doi.org\/10.3109\/10409238.2015.1091804","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"5794_CR13","first-page":"2596","volume":"21","author":"W Shen","year":"2017","unstructured":"Shen W, Li HL, Liu L, Cheng JX (2017) Expression levels of PTEN, HIF-1\u03b1, and VEGF as prognostic factors in ovarian cancer. Eur Rev Med Pharmacol Sci 21:2596\u20132603","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"5794_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3892\/ol_00000115","volume":"1","author":"Y Shi","year":"2010","unstructured":"Shi Y, Chang M, Wang F, Ouyang X, Jia Y, Du H (2010) Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231. Oncol Lett 1:657\u2013662. https:\/\/doi.org\/10.3892\/ol_00000115","journal-title":"Oncol Lett"},{"key":"5794_CR15","doi-asserted-by":"publisher","first-page":"680928","DOI":"10.3389\/fgene.2021.680928","volume":"12","author":"X Sun","year":"2021","unstructured":"Sun X, Huang Q, Peng F, Wang J, Zhao W, Guo G (2021) Expression and clinical significance of hkii and hif-1\u03b1 in grade groups of prostate cancer. Front Genet 12:680928. https:\/\/doi.org\/10.3389\/fgene.2021.680928","journal-title":"Front Genet"},{"key":"5794_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7497\/j.issn.2095-3941.2015.0030","volume":"12","author":"HA Wahba","year":"2015","unstructured":"Wahba HA, El-Hadaad HA (2015) Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med 12:106\u2013116. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2015.0030","journal-title":"Cancer Biol Med"},{"key":"5794_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3892\/ol.2019.11130","volume":"19","author":"J Wan","year":"2020","unstructured":"Wan J, Ling X, Rao Z, Peng B, Ding G (2020) Independent prognostic value of HIF-1\u03b1 expression in radiofrequency ablation of lung cancer. Oncol Lett 19:849\u2013857. https:\/\/doi.org\/10.3892\/ol.2019.11130","journal-title":"Oncol Lett"},{"key":"5794_CR18","doi-asserted-by":"publisher","first-page":"e2020490118","DOI":"10.1073\/pnas.2020490118","volume":"118","author":"R Wang","year":"2021","unstructured":"Wang R et al (2021) Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 118:e2020490118. https:\/\/doi.org\/10.1073\/pnas.2020490118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5794_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1515\/biol-2019-0025","volume":"14","author":"RX Wang","year":"2019","unstructured":"Wang RX, Ou XW, Kang MF, Zhou ZP (2019) Association of HIF-1\u03b1 and NDRG2 Expression with EMT in Gastric Cancer Tissues. Open Life Sci 14:217\u2013223. https:\/\/doi.org\/10.1515\/biol-2019-0025","journal-title":"Open Life Sci"},{"key":"5794_CR20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/med.21771","volume":"41","author":"L You","year":"2021","unstructured":"You L et al (2021) The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev 41:1622\u20131643. https:\/\/doi.org\/10.1002\/med.21771","journal-title":"Med Res Rev"},{"key":"5794_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/cbr.2017.2270","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Yan J, Wang L, Dai H, Li N, Hu W, Cai H (2017) HIF-1\u03b1 promotes breast cancer Cell MCF-7 proliferation and invasion through regulating miR-210. Cancer Biother Radiopharm 32:297\u2013301. https:\/\/doi.org\/10.1089\/cbr.2017.2270","journal-title":"Cancer Biother Radiopharm"},{"key":"5794_CR22","doi-asserted-by":"publisher","first-page":"9469","DOI":"10.1074\/jbc.M115.709337","volume":"291","author":"C Zhao","year":"2016","unstructured":"Zhao C, Brown RS, Tang CH, Hu CC, Schlieker C (2016) Site-specific proteolysis mobilizes TorsinA from the membrane of the endoplasmic reticulum (ER) in Response to ER stress and B Cell stimulation. J Biol Chem 291:9469\u20139481. https:\/\/doi.org\/10.1074\/jbc.M115.709337","journal-title":"J Biol Chem"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05794-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05794-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:52:09Z","timestamp":1720522329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05794-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["5794"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05794-3","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"GEO and TCGA database belong to public databases. The patients involved in the database have obtained ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on open source data, so there are no ethical issues and other conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"293"}}